12p12.1 microdeletion syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:313884OMIM:616803Q93.5
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

12p12.1 microdeletion syndrome is a rare genetic condition caused by a small missing piece (deletion) of genetic material on the short arm of chromosome 12, specifically at the region called 12p12.1. Because this deletion removes one or more important genes, it can affect how the body and brain develop. This condition is sometimes referred to as chromosome 12p12.1 deletion syndrome. Children born with this syndrome typically show developmental delays, meaning they may be slower to reach milestones like sitting, walking, and talking. Intellectual disability ranging from mild to moderate is common. Many affected individuals also have distinctive facial features, which may include a broad forehead, widely spaced eyes, a flat nasal bridge, and low-set ears. Some children may have growth problems, including short stature or feeding difficulties in infancy. Heart defects and other organ abnormalities have been reported in some cases. Because this is an extremely rare condition, there is no specific cure or targeted treatment. Management focuses on supportive care tailored to each person's needs, including early intervention therapies such as speech therapy, occupational therapy, and physical therapy. Regular monitoring by a team of specialists helps address medical issues as they arise. With appropriate support, many individuals can make meaningful developmental progress, though the degree of improvement varies from person to person.

Also known as:

Key symptoms:

Developmental delayIntellectual disabilitySpeech and language delaysShort stature or growth problemsDistinctive facial featuresBroad foreheadWidely spaced eyesFlat nasal bridgeLow-set earsFeeding difficulties in infancyLow muscle tone (floppiness)Heart defectsBehavioral difficultiesLearning difficulties

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for 12p12.1 microdeletion syndrome.

View clinical trials →

No actively recruiting trials found for 12p12.1 microdeletion syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the 12p12.1 microdeletion syndrome community →

No specialists are currently listed for 12p12.1 microdeletion syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to 12p12.1 microdeletion syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open 12p12.1 microdeletion syndromeForum →

No community posts yet. Be the first to share your experience with 12p12.1 microdeletion syndrome.

Start the conversation →

Latest news about 12p12.1 microdeletion syndrome

No recent news articles for 12p12.1 microdeletion syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is the exact size of my child's deletion, and which genes are affected?,Was this deletion inherited or did it happen spontaneously?,What therapies should we start right away, and how often should they occur?,Does my child need a heart evaluation or other organ screening?,What developmental milestones should I watch for, and when should I be concerned?,Are there any specialists we should see regularly?,What resources or support groups are available for families with this condition?

Common questions about 12p12.1 microdeletion syndrome

What is 12p12.1 microdeletion syndrome?

12p12.1 microdeletion syndrome is a rare genetic condition caused by a small missing piece (deletion) of genetic material on the short arm of chromosome 12, specifically at the region called 12p12.1. Because this deletion removes one or more important genes, it can affect how the body and brain develop. This condition is sometimes referred to as chromosome 12p12.1 deletion syndrome. Children born with this syndrome typically show developmental delays, meaning they may be slower to reach milestones like sitting, walking, and talking. Intellectual disability ranging from mild to moderate is com

At what age does 12p12.1 microdeletion syndrome typically begin?

Typical onset of 12p12.1 microdeletion syndrome is neonatal. Age of onset can vary across affected individuals.